Cellectar Biosciences, Inc. (CLRB): Shares Outstanding
4.24M
As of 2025-12-31
8.25M
As of 2026-06-30
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 4.24M | +176.1% | 2026-03-04, Balance as of period end |
| 2024-12-31 | 1.54M | n/c | 2026-03-04, Balance as of period end |
| 2023-12-31 | 20.74M | n/c | 2025-03-13, Balance as of period end |
| 2023-09-30 | 9.92M | n/a | 2024-10-29, Balance as of period end |
| 2023-06-30 | 9.74M | n/a | 2024-10-29, Balance as of period end |
| 2023-03-31 | 9.74M | n/a | 2024-10-29, Balance as of period end |
| 2022-12-31 | 9.39M | n/a | 2024-10-29, Balance as of period end |
| 2022-09-30 | 6.11M | n/a | 2024-10-29, Balance as of period end |
| 2022-06-30 | 6.11M | n/a | 2024-10-29, Balance as of period end |
| 2022-03-31 | 6.11M | n/a | 2024-10-29, Balance as of period end |
| 2021-12-31 | 6.11M | n/c | 2023-03-09, Balance as of period end |
| 2020-12-31 | 45.44M | n/c | 2022-03-21, Balance as of period end |
| 2019-12-31 | 9.39M | n/c | 2021-03-02, Balance as of period end |
| 2018-12-31 | 4.73M | +184.0% | 2020-03-09, Balance as of period end |
| 2017-12-31 | 1.67M | -83.9% | 2019-02-26, Balance as of period end |
| 2016-12-31 | 10.37M | n/m | 2018-03-21, Balance as of period end |
| 2015-12-31 | 858.1K | +13.5% | 2017-03-15, Balance as of period end |
| 2014-12-31 | 756.3K | -73.6% | 2016-10-20, Balance as of period end |
| 2013-12-31 | 2.87M | -93.8% | 2015-05-20, Balance as of period end |
| 2012-12-31 | 46.40M | +25.7% | 2014-03-19, Balance as of period end |
| 2011-12-31 | 36.91M | n/c | 2013-03-28, Balance as of period end |
| 2010-12-31 | 12.82M | n/a | 2012-03-09, Balance as of period end |